No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Evotec's Ongoing Bristol Myers Collaboration Triggers $75 Million Payments
Deutsche Bank Upgrades Evotec (0IRF) to a Hold
Evotec Deepens CELMoDs Alliance With Bristol Myers Squibb As Molecular Glue Degrader Pipeline Expands
Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration With Bristol Myers Squibb
Evotec (0IRF) Receives a Buy From Warburg Research
H.C. Wainwright Maintains Evotec(EVO.US) With Buy Rating, Maintains Target Price $8